Increased Serum Thymidine Kinase following Chemotherapy

Eriksson S Arner E Spasokoukotskaja T Wang L Karlsson A Brosjo O Properties and levels of deoxynucleotide kinases in normal and tumor cells; implications for chemotherapy. Advan Enzyme Regul 1994; 34: 13–25.

Romain S Martin PM Klijn JGM van Putten WLJ Look MP Guirou O. DNS-Synthesis enzyme activity: a biological tool useful for predicting antimetabolic drug sensitivity in breast cancer? Int J Cancer (Pred Oncol) 1997; 74: 156–61.

Bishop MR Coccia PF. Tumor lysis syndrome. In: Abeloff MD Armitage JO Lichter AS Niederhuber JE , eds. Clinical Oncology. New York: Churchill Livingstone; 1995: 557–61.

Khan J Broadbent VA. Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma. Pediat Hematol Oncol 1993; 10: 151–5.

Moss DW Henderson RA. Enzymes. In: Burtis C Ashwood ER , eds. Tietz Textbook of Clinical Chemistry. Pennsylvania: WB Saunders Company; 1992: 814–5.

Kalemkerian GP Darwish B Varterasian ML. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am J Med. 1997; 103: 363–7.